Evidence map›Paper›PMID 34458394›Full record

ArticleOpen forum infectious diseases2021

Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy.

Alain Makinson, Lesley S Park, Kimberly Stone, Janet Tate, Maria C Rodriguez-Barradas, Sheldon T Brown, Roxanne Wadia, Kristina Crothers, Roger Bedimo, Matthew Bidwell Goetz and 4 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  8. Open forum infectious diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Alain MakinsonUniversity Hospital Montpellier, Institut National de Science et de Recherche Médicale U1175 and University of Montpellier, Montpellier, France.
Lesley S ParkStanford University School of Medicine, Stanford, California, USA.
Kimberly StoneIcahn School of Medicine at Mt Sinai, New York, New York, USA.
Janet TateVeteran Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
Maria C Rodriguez-BarradasMichael E. DeBakey VAMC and Baylor College of Medicine, Houston, Texas, USA.
Sheldon T BrownJames J. Peters VA Medical Center, Bronx, New York, USA.
Roxanne WadiaVeteran Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
Kristina CrothersVA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
Roger BedimoVA North Texas Health Care Center, Dallas, Texas, USA.
Matthew Bidwell GoetzVA Greater Los Angeles Health Care System, Los Angeles, California, USA.
Fatma SheblMassachusetts General Hospital, Boston, Massachusetts, USA.
Jacques ReynesUniversity Hospital Montpellier, Institut National de Science et de Recherche Médicale U1175 and University of Montpellier, Montpellier, France.
Vincent Le MoingUniversity Hospital Montpellier, Institut National de Science et de Recherche Médicale U1175 and University of Montpellier, Montpellier, France.
Keith M SigelIcahn School of Medicine at Mt Sinai, New York, New York, USA.ORCID https://orcid.org/0000-0002-4051-4861
Université de Montpellier · FRIcahn School of Medicine at Mount Sinai · USVA Connecticut Healthcare System · USJames J. Peters VA Medical Center · USMassachusetts General Hospital · USMichael E. DeBakey VA Medical Center · USStanford University · USUniversity of Washington · USVA Greater Los Angeles Healthcare System · USVA North Texas Health Care System · US

Funding

Alcohol Associated Outcomes Among HIV+/-Aging VeteransU01AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2002 to 2005
$10.1M
Optimizing Lung Cancer Treatment in HIV Infected PersonsR01CA210806 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIGEL, KEITH MAGNUS · 2017 to 2020
$2.3M
NCI NIH HHS R01 CA210806NIAAA NIH HHS U01 AA013566
6 · The paper itself

Abstract

backgroundWe ascertained incidence of opportunistic infections (OIs) in people with human immunodeficiency virus (PWH) with cancer undergoing chemotherapy with non-human immunodeficiency virus (HIV) comparators.

methodsWe identified 2106 PWH and 2981 uninfected Veterans with cancer who received at least 1 dose of chemotherapy between 1996 and 2017 from the Veterans Aging Cohort Study. We ascertained incident OIs within 6 months of chemotherapy amongst zoster, cytomegalovirus, tuberculosis,

resultsWe confirmed 106 OIs in 101 persons. Adjusted OI incidence rate ratios (IRRs) indicated higher risk in PWH for all cancers (IRR, 4.8; 95% confidence interval [CI], 2.8-8.2), hematological cancers (IRR, 8.2; 95% CI, 2.4-27.3), and nonhematological cancers (IRR, 3.9; 95% CI, 2.1-7.2). Incidence rate ratios were not significantly higher in those with CD4 >200 cells/mm

conclusionsVeterans with HIV undergoing chemotherapy had higher rates of OIs than uninfected Veterans, particularly those with hematological cancers, but not in PWH with HIV controlled disease. Our study does not support systematic PCP prophylaxis in solid tumors in PWH with HIV controlled disease.

Indexed as

Cancerchemotherapyopportunistic infectionsPneumocystis jirovecii pneumoniaprophylaxis

Identifiers

PMID34458394
PMCPMC8391784
OpenAlexW3185304638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.